Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Madrigal Pharmaceuticals Inc
(NQ:
MDGL
)
256.85
+0.68 (+0.27%)
Streaming Delayed Price
Updated: 9:30 AM EDT, Aug 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Madrigal Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
Next >
Is Madrigal Pharmaceuticals Stock a Buy?
August 17, 2024
The biotech could be worth a lot more in 10 years.
Via
The Motley Fool
This 1 Setback for Novo Nordisk Is Bullish for Madrigal Pharmaceuticals Stock
August 14, 2024
One player's minor pain is another's moderate gain.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
August 12, 2024
Via
Benzinga
Biotech Stocks: Why Acadia Pharma And Others Are Feeling 'Growing Pains'
August 07, 2024
Acadia led a biotech selloff on Wednesday as Daybue sales missed expectations.
Via
Investor's Business Daily
Topics
Earnings
Exposures
Financial
Is It Too Late to Buy Madrigal Pharmaceuticals Stock?
August 05, 2024
Will being the first to its market ensure that its future is bright?
Via
The Motley Fool
Is Madrigal Pharmaceuticals Stock a Buy?
May 21, 2024
It's not the most prominent biotech, but it has an important claim to fame.
Via
The Motley Fool
2 Under-the-Radar Growth Stocks to Consider
April 10, 2024
Don't ignore these innovative companies.
Via
The Motley Fool
1 No-Brainer Growth Stock to Buy Now
April 03, 2024
This liver-disease specialist might be significantly undervalued.
Via
The Motley Fool
7 Biotech Stocks to Keep on Your Clinical Radar
July 23, 2024
Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs.
Via
InvestorPlace
Is Madrigal Pharmaceuticals a Millionaire Maker?
June 30, 2024
Its revenue ramp-up is just starting, and its market looks lucrative.
Via
The Motley Fool
Is Madrigal Pharmaceuticals Stock a Buy?
June 28, 2024
The company could become a prominent player in the biotech industry, but that might take a while.
Via
The Motley Fool
The Best Biotech Stock to Invest $1,000 in Right Now
June 18, 2024
This stock may not be a slam dunk, but it's looking very promising.
Via
The Motley Fool
Gilead Has A Narrative-Changing Revelation For Its Weight-Loss Contender
June 17, 2024
The company tested a GLP-1 drug in monkeys. But it might not actually be an obesity treatment.
Via
Investor's Business Daily
Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.
June 16, 2024
Eli Lilly just drizzled on Madrigal Pharmaceuticals' parade.
Via
The Motley Fool
Where Will Madrigal Pharmaceuticals Be in 3 Years?
June 15, 2024
The coast is clear for it to grow, for now.
Via
The Motley Fool
Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade
June 12, 2024
On Wednesday, Madrigal Pharmaceuticals stock earned an upgrade to its Relative Strength (RS) Rating, from 74 to 90.
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
June 11, 2024
Via
Benzinga
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
June 10, 2024
Success isn't guaranteed, but both companies could become big winners.
Via
The Motley Fool
What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
June 05, 2024
Madrigal Pharmaceuticals and Sagimet Biosciences shares fall following Eli Lilly's presentation at the EASL Liver Congress 2024. Phase 2 tirzepatide trial shows promising results for MASH treatment....
Via
Benzinga
Madrigal, Akero, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASH
June 05, 2024
Researchers published results Wednesday showing Lilly's weight-loss drug could work in a liver disease.
Via
Investor's Business Daily
DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
June 05, 2024
Via
Benzinga
Viking Therapeutics Stock Crumbles Despite Potential 'Best-In-Class' Liver Disease Drug
June 04, 2024
Viking Therapeutics stock falls despite seemingly positive test results for a drug that treats a serious liver disease.
Via
Investor's Business Daily
The Week Ahead: What's Next
June 02, 2024
The core part of our portfolio is up 24% this year ... and we're about to add another stock. Plus, a riddle.
Via
Talk Markets
MDGL Stock Earnings: Madrigal Pharmaceuticals Misses EPS for Q1 2024
May 07, 2024
MDGL stock results show that Madrigal Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 07, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
May 03, 2024
Via
Benzinga
7 Stocks Analysts Are Loving Right Now (And You Should Too): April 2024
April 15, 2024
Analyst-backed stocks have a high correlation with future stock price growth. Here are seven stocks with a high number of recent upgrades.
Via
InvestorPlace
Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics
April 05, 2024
These businesses should see good times ahead.
Via
The Motley Fool
The 3 Best Biotech Stocks to Buy in April 2024
April 01, 2024
Biotech is one of the hottest sectors on the market, creating big opportunities for some of the best biotech stocks to buy in April.
Via
InvestorPlace
2 Top Biotech Buyout Candidates
March 31, 2024
Investors who are adventurous, have a high-risk tolerance, and are home run hitters may opt for biotech stocks. Investors in this group may want to hone in on stocks that have the potential to be...
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.